These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2107558)

  • 1. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
    Jenck F; Broekkamp CL; Van Delft AM
    Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
    Kennett GA; Curzon G
    Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of 5-HT1C-receptors in drug-induced penile erections in rats.
    Berendsen HH; Jenck F; Broekkamp CL
    Psychopharmacology (Berl); 1990; 101(1):57-61. PubMed ID: 2343074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.
    Kennett GA; Whitton P; Shah K; Curzon G
    Eur J Pharmacol; 1989 May; 164(3):445-54. PubMed ID: 2767117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion.
    Jenck F; Broekkamp CL; Van Delft AM
    Eur J Pharmacol; 1989 Feb; 161(2-3):219-21. PubMed ID: 2524392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
    Jackson DA; White SR
    Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of brainstem 5-HT1C receptors by serotonergic drugs in the rat.
    Pranzatelli MR; Tailor PT
    Gen Pharmacol; 1994 Oct; 25(6):1279-84. PubMed ID: 7875557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH; Broekkamp CL
    Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
    Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
    Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
    Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
    Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists.
    Pranzatelli MR; Murthy JN; Tailor PT
    Eur J Pharmacol; 1993 Jan; 244(1):1-5. PubMed ID: 8420788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity.
    Neuman RS; Zebrowska G
    Can J Physiol Pharmacol; 1992 Dec; 70(12):1604-9. PubMed ID: 1301238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion.
    Nogueira RL; Graeff FG
    Pharmacol Biochem Behav; 1995 Sep; 52(1):1-6. PubMed ID: 7501649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.